Vylor Inc.

Aktienanalyse zu Vylor Inc. (VYLR)

$73.940

-0.643 (-0.87%)Zum Schluss

Loading chart…
Hoch
74.900
Eröffnung
74.590
Volumengewichteter Durchschnittskurs
73.47
Volumen
4.42M
Marktkap.
—
Tief
71.580
Umsatz
324.63M
EV/EBITDA, TTM
13.67

Vylor Inc. is focused in the seed business, including its global growth platforms in licensing, gene editing, hybrid wheat, and biofuels. The Company is a global seed producer utilizing cutting-edge technology, including advanced genetics and proprietary traits that increase yield, sustainability, and crop heal.

www.vylor.com

KI-Analyse of Vylor Inc. (VYLR)

Kaufen

Vylor Inc. is a good buy right now due to its recent performance and positive analyst outlook. The current price is $74.59, which is below the average analyst price target of $87, indicating a potential upside of 16.5%. Additionally, the company has launched a $3 billion share repurchase program, which signals strong confidence in its future performance. However, the high PE ratio of 193.71 poses a risk as it suggests the stock may be overvalued if growth does not meet expectations.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Vylor Inc. (VYLR) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
11.86
Aktuelles EV/EBITDA
13.67
Überbewertet
14.26
Unterbewertet
9.45

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
3.97
Aktuelles P/S
4.62
Überbewertet
4.84
Unterbewertet
3.09

Whales, die VYLR halten

A

Anomaly Capital Management, LP

+ HältVYLR

-4.80%

3-Monats-Rendite

VYLR FAQ – beantwortet von Alphio AI

Vylor Inc. is focused in the seed business, including its global growth platforms in licensing, gene editing, hybrid wheat, and biofuels. The Company is a global seed producer utilizing cutting-edge technology, including advanced genetics and proprietary traits that increase yield, sustainability, and crop heal.

Vylor Inc. is a good buy right now due to its recent performance and positive analyst outlook. The current price is $74.59, which is below the average analyst price target of $87, indicating a potential upside of 16.5%. Additionally, the company has launched a $3 billion share repurchase program, which signals strong confidence in its future performance. However, the high PE ratio of 193.71 poses a risk as it suggests the stock may be overvalued if growth does not meet expectations.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln